478 related articles for article (PubMed ID: 30602477)
1. Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.
Defreyne J; Van de Bruaene LDL; Rietzschel E; Van Schuylenbergh J; T'Sjoen GGR
Clin Chem; 2019 Jan; 65(1):119-134. PubMed ID: 30602477
[TBL] [Abstract][Full Text] [Related]
2. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
Connelly PJ; Marie Freel E; Perry C; Ewan J; Touyz RM; Currie G; Delles C
Hypertension; 2019 Dec; 74(6):1266-1274. PubMed ID: 31656099
[TBL] [Abstract][Full Text] [Related]
3. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
Streed CG; Harfouch O; Marvel F; Blumenthal RS; Martin SS; Mukherjee M
Ann Intern Med; 2017 Aug; 167(4):256-267. PubMed ID: 28738421
[TBL] [Abstract][Full Text] [Related]
5. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women.
Haupt C; Henke M; Kutschmar A; Hauser B; Baldinger S; Saenz SR; Schreiber G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013138. PubMed ID: 33251587
[TBL] [Abstract][Full Text] [Related]
7. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
8. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
9. Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review.
Defreyne J; Motmans J; T'sjoen G
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):543-556. PubMed ID: 28972413
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
[No Abstract] [Full Text] [Related]
12. Gender-Affirming Hormone Therapy for Transgender Men.
Moravek MB
Clin Obstet Gynecol; 2018 Dec; 61(4):687-704. PubMed ID: 30285972
[TBL] [Abstract][Full Text] [Related]
13. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.
Turino Miranda K; Kalenga CZ; Saad N; Dumanski SM; Collister D; Rytz CL; Lorenzetti DL; Chang DH; McClurg C; Sola DY; Ahmed SB
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H861-H868. PubMed ID: 36053748
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Gender-Affirming Hormone Therapy Requirements.
Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
[TBL] [Abstract][Full Text] [Related]
16. Position statement on the hormonal management of adult transgender and gender diverse individuals.
Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease in transgender people: a systematic review and meta-analysis.
van Zijverden LM; Wiepjes CM; van Diemen JJK; Thijs A; den Heijer M
Eur J Endocrinol; 2024 Feb; 190(2):S13-S24. PubMed ID: 38302717
[TBL] [Abstract][Full Text] [Related]
18. Gender-Affirming Hormone Therapy for Transgender Females.
Randolph JF
Clin Obstet Gynecol; 2018 Dec; 61(4):705-721. PubMed ID: 30256230
[TBL] [Abstract][Full Text] [Related]
19. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.
Amir H; Yaish I; Samara N; Hasson J; Groutz A; Azem F
J Assist Reprod Genet; 2020 Oct; 37(10):2463-2472. PubMed ID: 32719977
[TBL] [Abstract][Full Text] [Related]
20. Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram.
Saito N; Nagahara D; Ichihara K; Masumori N; Miura T; Takahashi S
Heart Rhythm; 2021 Jul; 18(7):1203-1209. PubMed ID: 33706005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
